Edit |   |
---|---|
Antigenic Specificity | IL6, Human (Clazakizumab biosimilar) |
Clone | Clazakizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL6 Recombinant Antibody (Clazakizumab). Clazakizumab (formerly ALD518 and BMS-945429), an investigational drug, is an aglycosylated, humanized rabbit monoclonal antibody against interleukin-6.[1] Clazakizumab was developed by Bristol Myers Squib and Alder Biopharmaceuticals. |
Immunogen | n/a |
Other Names | Anti-IL6 Recombinant Antibody, Research Grade Clazakizumab, Anti-Human IL6 Recombinant Antibody(Clazakizumab), ALD-518, BMS-945429, Antibody Drug Analogues, Monoclonal Antibody, YR1275, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1236278-28-6 |
Catalog # | YR1275 |
Price | please inquire |
Order / More Info | IL6, Human (Clazakizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |